|
|
Volumn 38, Issue 3 SUPPL., 2002, Pages 79-80
|
|
Role of supportive care in the treatment of NSCLC: Supportive care for myelotoxicity
|
|
Author keywords
Chemotherapy; Myelotoxicity; NSCLC; Supportive care
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
RECOMBINANT INTERLEUKIN 11;
RECOMBINANT THROMBOPOIETIN;
ADVANCED CANCER;
ARTICLE;
BONE MARROW SUPPRESSION;
BONE MARROW TOXICITY;
CANCER CHEMOTHERAPY;
CANCER PALLIATIVE THERAPY;
CANCER STAGING;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG WITHDRAWAL;
FEBRILE NEUTROPENIA;
HUMAN;
LUNG NON SMALL CELL CANCER;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
THROMBOCYTOPENIA;
TREATMENT CONTRAINDICATION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
|
|
EID: 0036893861
PISSN: 01695002
EISSN: None
Source Type: Journal
DOI: 10.1016/s0169-5002(02)00276-3 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
